Biogen appoints Feire as Head of Business Development and External Innovation

Biogen (BIIB) announced the appointment of Adam Feire, Ph.D., as Head of Business Development and External Innovation. Feire reports to Adam Keeney, Ph.D., Executive Vice President and Head of Corporate Development. In this role, Feire leads the search and evaluation of external opportunities and is responsible for business development transactions including mergers and acquisitions. “Adam Feire brings nearly two decades of pharmaceutical industry experience to Biogen, most recently as the Global Head of Search & Evaluation within Novartis (NVS) Corporate & Business Development,” the company stated. “Adam Feire’s extensive business development experience, combined with his track record of building strategic alliances, will help advance Biogen’s goals to achieve sustainable growth. As we look to invest in a diversified pipeline through business development, Adam’s expertise will be instrumental in identifying, evaluating and securing meaningful partnerships to further strengthen the Biogen portfolio,” added Adam Keeney.